• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Actinium Pharmaceuticals - Articles and news items

Iomab-B

FDA grants orphan drug designation to Iomab-B

Industry news / 31 March 2016 / Victoria White

Actinium’s Iomab-B is a radioimmunotherapeutic that conditions relapsed and refractory AML patients for a haematopoietic stem cell transplant…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +